β-cryptoxanthin reduced lung tumor multiplicity and inhibited lung cancer cell motility by downregulating nicotinic acetylcholine receptor α7 signaling

Cancer Prevention Research

Volumn 9, Issue 11, 2016, Pages 875-886

  Iskandar, Anita R ^a   Miao, Benchun ^a   Li, Xinli ^a   Hu, Kang Quan ^a   Liu, Chun ^a   Wang, Xiang Dong ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; BETA CRYPTOXANTHIN; MESSENGER RNA; NICOTINIC ACETYLCHOLINE RECEPTOR ALPHA7; NICOTINIC RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; RETINOL; RETINOL PALMITATE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; BUNGAROTOXIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL MOTILITY; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG DOSE COMPARISON; DRUG MECHANISM; DRUG RESPONSE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; LUNG PARENCHYMA; MALE; MIGRATION INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TISSUE LEVEL; TUMOR INVASION; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; ANIMAL; CELL MOTION; DRUG EFFECTS; LUNG TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; ANIMALS; ANTINEOPLASTIC AGENTS; BETA-CRYPTOXANTHIN; CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; HUMANS; LUNG NEOPLASMS; MICE; SIGNAL TRANSDUCTION;

EID: 84994753573     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-16-0161     Document Type: Article

References (50)

1. Iskandar AR, Wang XD. Carotenoids and Vitamin A in Lung Cancer Prevention. In: Sommerburg O, Siems W, Kraemer K, eds. Carotenoids and vitamin A in translational medicine. New York, NY: CRC Press, 2013:273-88.
2. Mäannistö S, Smith-Warner SA, Spiegelman D, Albanes D, Anderson K, van den Brandt PA, et al. Dietary carotenoids and risk of lung cancer in a pooled analysis of seven cohort studies. Cancer Epidemiol Biomarkers Prev 2004; 13:40-8.
3. Min KB, Min JY. Serum carotenoid levels and risk of lung cancer death in U.S. adults. Cancer Sci 2014; 105:736-43.
4. Yuan JM, Ross RK, Chu XD, Gao YT, Yu MC. Prediagnostic levels of serum beta-cryptoxanthin and retinol predict smoking-related lung cancer risk in Shanghai, China. Cancer Epidemiol Biomarkers Prev 2001; 10:767-73.
5. Yuan JM, Stram DO, Arakawa K, Lee HP, Yu MC. Dietary cryptoxanthin and reduced risk of lung cancer: the Singapore Chinese Health Study. Cancer Epidemiol Biomarkers Prev 2003; 12:890-8.
6. Lian F, Hu KQ, Russell RM, Wang XD. Beta-cryptoxanthin suppresses the growth of immortalized human bronchial epithelial cells and non-small-cell lung cancer cells and up-regulates retinoic acid receptor beta expression. Int J Cancer 2006; 119:2084-9.
7. Liu C, Bronson RT, Russell RM, Wang XD. Beta-Cryptoxanthin supplementation prevents cigarette smoke-induced lung inflammation, oxidative damage, and squamous metaplasia in ferrets. Cancer Prev Res 2011; 4: 1255-66.
8. Iskandar AR, Liu C, Smith DE, Hu K-Q, Choi S-W, Ausman LM, et al. Beta-cryptoxanthin restores nicotine-reduced lung SIRT1 to normal levels and inhibits nicotine-promoted lung tumorigenesis and emphysema in A/J mice. Cancer Prev Res 2013; 6:309-20.
9. Hecht SS Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer 2003; 3:733-44.
10. Grando SA Connections of nicotine to cancer. Nat Rev Cancer 2014; 14: 419-29.
11. Schuller HM Is cancer triggered by altered signalling of nicotinic acetyl-choline receptors? Nat Rev Cancer 2009; 9:195-205.
12. Grozio A, Paleari L, Catassi A, Servent D, Cilli M, Piccardi F, et al. Natural agents targeting the alpha7-nicotinic-receptor in NSCLC: a promising prospective in anti-cancer drug development. Int J Cancer 2008; 122: 1911-5.
13. Zhao Y. The oncogenic functions of nicotinic acetylcholine receptors. J Oncol 2016; 2016:9650481.
14. Brown KC, Perry HE, Lau JK, Jones DV, Pulliam JF, Thornhill BA, et al. Nicotine induces the up-regulation of the alpha7-nicotinic receptor (alpha7-nAChR) in human squamous cell lung cancer cells via the Sp1/GATA protein pathway. J Biol Chem 2013; 288:33049-59.
15. Yang L, Lu X, Qiu F, Fang W, Zhang L, Huang D, et al. Duplicated copy of CHRNA7 increases risk and worsens prognosis of COPD and lung cancer. Eur J Hum Genet 2015; 23:1019-24.
16. Catassi A, Servent D, Paleari L, Cesario A, Russo P. Multiple roles of nicotine on cell proliferation and inhibition of apoptosis: implications on lung carcinogenesis. Mutat Res 2008; 659:221-31.
17. Egleton RD, Brown KC, Dasgupta P. Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and inhibition of apoptosis. Trends Pharmacol Sci 2008; 29:151-8.
18. Plummer HK III, Dhar M, Schuller HM. Expression of the alpha7 nicotinic acetylcholine receptor in human lung cells. Respir Res 2005; 6:29.
19. Aizawa K, Liu C, Tang S, Veeramachaneni S, Hu KQ, Smith DE, et al. Tobacco carcinogen (NNK) induces both lung cancer and non-alcoholic steatohepatitis and hepatocellular carcinomas in ferrets which can be attenuated by lycopene supplementation. Int J Cancer 2016; 139: 1171-81.
20. Memmott RM, Dennis PA. The role of the Akt/mTOR pathway in tobacco carcinogen-induced lung tumorigenesis. Clin Cancer Res 2010; 16:4-10.
21. West KA, Brognard J, Clark AS, Linnoila IR, Yang X, Swain SM, et al. Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin Invest 2003; 111:81-90.
22. Vivanco I, Sawyers CL. The phosphatidylinositol 3-kinase-AKT pathway in human cancer. Nat Rev Cancer 2002; 2:489-501.
23. Eden S, Rohatgi R, Podtelejnikov AV, Mann M, Kirschner MW. Mechanism of regulation of WAVE1-induced actin nucleation by Rac1 and Nck. Nature 2002; 418:790-3.
24. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, et al. Cell migration: integrating signals from front to back. Science 2003; 302:1704-9.
25. Pauly JR Gender differences in tobacco smoking dynamics and the neuropharmacological actions of nicotine. Front BioSci 2007; 13:505-16.
26. 0-lycopenoic acid inhibits lung cancer cell growth invitro, and suppresses lung tumorigenesis in the A/J mouse model in vivo. Carcinogenesis 2007; 28:1567-74.
27. Mernitz H, Smith DE, Wood RJ, Russell RM, Wang XD. Inhibition of lung carcinogenesis by 1alpha, 25-dihydroxyvitamin D3 and 9-cis retinoic acid in the A/J mouse model: evidence of retinoid mitigation of vitamin D toxicity. Int J Cancer 2007; 120:1402-9.
28. Liu C, Lian F, Smith DE, Russell RM, Wang X-D. Lycopene supplementation inhibits lung squamous metaplasia and induces apoptosis via up-regulating insulin-like growth factor-binding protein3 in cigarette smoke-exposed ferrets. Cancer Res 2003; 63:3138-44.
29. Lee CM, Boileau AC, Boileau TW, Williams AW, Swanson KS, Heintz KA, et al. Review of animal models in carotenoid research. J Nutr 1999; 129: 2271-7.
30. Nagavarapu U, Danthi S, Boyd RT. Characterization of a rat neuronal nicotinic acetylcholine receptor alpha7 promoter. J Biol Chem 2001; 276: 16749-57.
31. Shin VY, Wu WK, Chu K-M, Wong HP, Lam EK, Tai EK, et al. Nicotine induces cyclooxygenase-2 and vascular endothelial growth factor receptor-2 in association with tumor-associated invasion and angiogenesisin gastric cancer. Mol Cancer Res 2005; 3:607-15.
32. Guo J, Ibaragi S, Zhu T, Luo L-Y, Hu G-F, Huppi PS, et al. Nicotine promotes mammary tumor migration via a signaling cascade involving protein kinase C and CDC42. Cancer Res 2008; 68:8473-81.
33. Beraldo FH, Arantes CP, Santos TG, Queiroz NG, Young K, Rylett RJ, et al. Role of alpha7 nicotinic acetylcholine receptor in calcium signaling induced by prion protein interaction with stress-inducible protein 1. J Biol Chem 2010; 285:36542-50.
34. Lee CH, Huang CS, Chen CS, Tu SH, Wang YJ, Chang YJ, et al. Over-expression and activation of the alpha9-nicotinic receptor during tumorigenesis in human breast epithelial cells. J Natl Cancer Inst 2010; 102: 1322-35.
35. Cain RJ, Ridley AJ. Phosphoinositide 3kinases in cell migration. Biol Cell 2009; 101:13-29.
36. Donaldson JG Multiple roles for Arf6: sorting, structuring, and signaling at the plasma membrane. J Biol Chem 2003; 278:41573-6.
37. Gallicchio L, Boyd K, Matanoski G, Tao XG, Chen L, Lam TK, et al. Carotenoids and the risk of developing lung cancer: a systematic review. Am J Clin Nutr 2008; 88:372-83.
38. Paleari L, Catassi A, Ciarlo M, Cavalieri Z, Bruzzo C, Servent D, et al. Role of a-7nicotinic acetylcholine receptor in human nonsmall cell lung cancer proliferation. Cell Prolif 2008; 41:936-59.
39. Improgo MR, Tapper AR, Gardner PD. Nicotinic acetylcholine receptor-mediated mechanisms in lung cancer. Biochem Pharmacol 2011; 82: 1015-21.
40. Paleari L, Negri E, Catassi A, Cilli M, Servent D, D'Angelillo R, et al. Inhibition of nonneuronal alpha7-nicotinic receptor for lung cancer treatment. Am J Respir Crit Care Med 2009; 179:1141-50.
41. Wang XD Carotenoids. In: Ross AC, Caballero B, Cousins RJ, Tucker KL, Ziegler TR, eds. Modern nutrition in health and disease. 11th ed. Philadelphia, PA: Lippincott Williams & Wilkins 2012:427-437.
42. National Nutrient Database USDA. Cryptoxanthin, beta (microgram) Content of Selected Food per Common Measure. Available at https://www.ars.usda.gov/SP2UserFiles/Place/12354500/Data/SR24/nutrlist/sr24w334.pdf Accessed: March 2012.
43. Schmitz HH, Poor CL, Wellman RB, Erdman JW Jr Concentrations of selected carotenoids and vitamin A in human liver, kidney and lung tissue. J Nutr 1991; 121:1613-21.
44. Dahl AR, Grossi IM, Houchens DP, Scovell LJ, Placke ME, Imondi AR, et al. Inhaled isotretinoin (13-cis retinoic acid) is an effective lung cancer chemopreventive agent in A/J mice at low doses: a pilot study. Clin Cancer Res 2000; 6:3015-24.
45. Goralczyk R, Bachmann H, Wertz K, Lenz B, Riss G, Buchwald Hunziker P, et al. Beta-carotene-induced changes in RAR beta isoformm RNA expression patterns do not influence lung adenoma multiplicity in the NNK-initiated A/J mouse model. Nutr Cancer 2006; 54:252-62.
46. Wang XD, Liu C, Bronson RT, Smith DE, Krinsky NI, Russell M. Retinoid signaling and activator protein-1 expression in ferrets given beta-carotene supplements and exposed to tobacco smoke. J Natl Cancer Inst 1999; 91:60-6.
47. Uray IP, Dmitrovsky E, Brown PH. Retinoids and rexinoids in cancer prevention: from laboratory to clinic. Semin Oncol 2016; 43:49-64.
48. Matsumoto A, Mizukami H, Mizuno S, Umegaki K, Nishikawa J, Shudo K, et al. Beta-Cryptoxanthin, a novel natural RAR ligand, induces ATP-binding cassette transporters in macrophages. Biochem Pharmacol 2007; 74:256-64.
49. Fu H, Wu C, Riaz H, Zhang H, Han L, Bai L, et al. Beta-Cryptoxanthin uptake in THP-1 macrophages upregulates the CYP27A1 signaling pathway. Mol Nutr Food Res 2014; 58:425-36.
50. Shirakura Y, Takayanagi K, Mukai K, Tanabe H, Inoue M. beta-cryptox-anthin suppresses the adipogenesis of 3T3-L1 cells via RAR activation. J Nutr Sci Vitaminol 2011; 57:426-31.